ANGELINI, SABRINA
Dettaglio
ANGELINI, SABRINA
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
Docenti di ruolo di IIa fascia
Pubblicazioni
Risultati 1 - 20 di 81 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | A genetic perspective to the response to pt-based chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: toward a customized chemotherapy. | AFFATATO A.A.; M. PAPI; M. VALLI; S. ANGELINI; P. HRELIA; A. RAVAIOLI; G. CANTELLI FORTI | 2009 | Società Italiana di Farmacologia | 4.02 Riassunto (Abstract) | - | |
2 | A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels | Rosticci, Martina; Pervjakova, Natalia; Kaakinen, Marika; Cicero, Arrigo F; Feufer, Arne P; Marul...lo, Letizia; Mägi, Reedik; Fischer, Krista; Jiang, Longda; D'Addato, Sergio; Rizzoli, Elisabetta; Massimo, Gianmichele; Giovannini, Marina; Angelini, Sabrina; Hrelia, Patrizia; Scapoli, Chiara; Borghi, Claudio; Prokopenko, Inga | 2019 | BIOMARKERS IN MEDICINE | 1.01 Articolo in rivista | ||
3 | A nutraceutical lesson from Brassica vegetables: cardioprotection by sulforaphane. | E. Leoncini; C. Angeloni; M. Malaguti; S. Angelini; P. Hrelia; S. Hrelia | 2008 | ITALIAN JOURNAL OF AGRONOMY | 1.01 Articolo in rivista | - | |
4 | ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis. | Zheng Q;Wu H;Yu Q;Kim DH;Lipton JH;Angelini S;Soverini S;Vivona D;Takahashi N;Cao J | 2015 | PHARMACOGENOMICS JOURNAL | 1.01 Articolo in rivista | - | |
5 | Absence of mutations in the human interferon alpha-2b gene in workers chronically exposed to ionising radiation | Botbayev, Dauren; Ravegnini, Gloria; Sammarini, Giulia; Kazymbet, Polat; Cilli, Elisabetta; Serve...nti, Patrizia; Khanseitova, Alexandra; Alzhanuly, Bakhytzhan; Belkozhaev, Ayaz; Aitkhozhina, Nagima; Bakhtin, Meirat; Lodi, Vittorio; Hrelia, Patrizia; Angelini, Sabrina | 2019 | ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU | 1.01 Articolo in rivista | - | |
6 | Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells | Olivieri F;Bonafè M;Spazzafumo L;Gobbi M;Prattichizzo F;Recchioni R;Marcheselli F;La Sala L;Galea...zzi R;Rippo MR;Fulgenzi G;Angelini S;Lazzarini R;Bonfigli AR;Brugè F;Tiano L;Genovese S;Ceriello A;Boemi M;Franceschi C;Procopio AD;Testa R | 2014 | AGING | 1.01 Articolo in rivista | - | |
7 | Analisi di polimorfismi in geni coinvolti nel ciclo dei folati come determinanti di suscettibilità a leucemia mieloide cronica. | TURRINI E.; S. ANGELINI; S. SOVERINI; M. BACCARANI; G. CANTELLI FORTI; P. HRELIA | 2009 | Società Italiana di Tossicologia | 4.02 Riassunto (Abstract) | - | |
8 | Application of the lymphocyte Cytokinesis-Block Micronucleus Assay to populations exposed to petroleum and its derivatives: Results from a systematic review and meta-analysis | Angelini, Sabrina; Bermejo, Justo Lorenzo; Ravegnini, Gloria; Sammarini, Giulia; Hrelia, Patrizia | 2016 | MUTATION RESEARCH. REVIEWS IN MUTATION RESEARCH | 1.01 Articolo in rivista | - | |
9 | Association between genotypes and response to imatinib mesylate treatment in a subset of previously untreated patients affected by gastrointestinal stromal tumours. | ANGELINI S.; M. PANTALEO; E. TURRINI; M. DI BATTISTA; G. CANTELLI FORTI; G. BIASCO; P. HRELIA | 2010 | European Science Foundation | 4.02 Riassunto (Abstract) | - | |
10 | Association between genotypes and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the TOPS trial. | ANGELINI S.; S. POVERINI; E. TURRINI; G. PERINI; F. PANE; F. QUARANTELLI; T. HUGHES; D. WHITE; D....W. KIM; H. GOH; J. RADICH; L. BEPPU; G. SAGLIO; D. CILLONI; C. TERRAGNA; I. IACOBUCCI; P. HRELIA; G. CANTELLI FORTI; T. KALEBIC; M. THORNQUIST; M. BACCARANI; G. MARTINELLI | 2010 | s.n | 4.02 Riassunto (Abstract) | - | |
11 | Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy | Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White... DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G | 2013 | HAEMATOLOGICA | 1.01 Articolo in rivista | ||
12 | Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma Tumors | Scherer D.; Rachakonda P.S.; Angelini S.; Mehnert F.; Sucker A.; Egberts F.; Hauschild A.; Hemmin...ki K.; Schadendorf D.; Kumar R. | 2010 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1.01 Articolo in rivista | - | |
13 | Association between transporters genotype and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the tops trial. | ANGELINI S.; SOVERINI S.; TURRINI E.; PERINI G.; PANE F.; QUARANTELLI F.; HUGHES T.; WHITE D.; KI...M D.W.; GOH H.; RADICH J.; BEPPU L.; SAGLIO G.; CILLONI D.; TERRAGNA C.; IACOBUCCI I.; HRELIA P.; CANTELLI FORTI G.; KALEBIC T.; THORNQUIST M.; BACCARANI M.; MARTINELLI G. | 2009 | Società Italiana di Tossicologia | 4.02 Riassunto (Abstract) | - | |
14 | Biomarcatori genetici e di suscettibilità per la valutazione del rischio da benzene ambientale in agenti di polizia. | Maffei F.; Angelini S.; Carbone F.; Cantelli Forti G.; Kumar R.; Hemminki K.; Violante F.S.; Hrel...ia P. | 2006 | Istituto Superiore di Sanità | 4.02 Riassunto (Abstract) | - | |
15 | Biomarker study to assess health risk in human occupationally exposed to environmental benzene. | Maffei F.; Angelini S.; Cantelli Forti G.; Carbone F.; Violante F.S.; Kumar R.; Hemminki K.; Hrel...ia P. | 2004 | DISEASE MARKERS | 4.02 Riassunto (Abstract) | - | |
16 | Biomarkers of susceptibility and effects in humans occupationally exposed to urban air pollution. | ANGELINI S.; F. MAFFEI; R. KUMAR; F. CARBONE; E. TURRINI; G. CANTELLI FORTI; K. HEMMINKI; P. HRELIA | 2009 | European Environmental Mutagen Society | 4.02 Riassunto (Abstract) | - | |
17 | Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal Neoplasia | Francesca Maffei;Sabrina Angelini;Giorgio Cantelli Forti;Patrizia Hrelia | 2013 | CURRENT COLORECTAL CANCER REPORTS | 1.01 Articolo in rivista | - | |
18 | BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival | Akslen LA; ANGELINI S; Straume O; Bachmann IM; Molven A; Hemminki K; Kumar R | 2005 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1.01 Articolo in rivista | - | |
19 | BRAF mutations are common somatic events in melanocytic nevi. | Kumar R; Angelini S; Snellman E; Hemminki K. | 2004 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1.01 Articolo in rivista | - | |
20 | The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. | Di Paolo A;Polillo M;Capecchi M;Cervetti G;Baratè C;Angelini S;Guerrini F;Fontanelli G;Arici R;Ci...abatti E;Grassi S;Bocci G;Hrelia P;Danesi R;Petrini M;Galimberti S | 2014 | PHARMACOGENOMICS JOURNAL | 1.01 Articolo in rivista | - |